Jinghan Zhu

178 East Ganjiang Road
Suzhou, 215000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Low SLC8A1 in Colorectal Cancer Dictates Radiotherapy Resistance Through Calcium-Dependent ANXA2+sEVs Driving M2 Polarization of TAMs.

Low SLC8A1 in Colorectal Cancer Dictates Radiotherapy Resistance Through Calcium-Dependent ANXA2+sEVs Driving M2 Polarization of TAMs.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 03, 2026

Mitochondrial metabolic remodeling predicts therapeutic response to PegIFN-α in chronic hepatitis B.

Mitochondrial metabolic remodeling predicts therapeutic response to PegIFN-α in chronic hepatitis B.

Journal: Frontiers in cellular and infection microbiology

Published: October 06, 2025

MRI Monitoring of Locally Advanced Rectal Cancer in Watch and Wait Patients.

MRI Monitoring of Locally Advanced Rectal Cancer in Watch and Wait Patients.

Journal: Clinical colorectal cancer

Published: April 15, 2025

Associations of estimated glucose disposal rate with frailty progression: results from two prospective cohorts.

Associations of estimated glucose disposal rate with frailty progression: results from two prospective cohorts.

Journal: Cardiovascular diabetology

Published: December 31, 2024

Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF-κB Pathway.

Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF-κB Pathway.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 09, 2024

Identification and evaluation of plasma exosome RNA biomarkers for non-invasive diagnosis of hepatocellular carcinoma using RNA-seq.

Identification and evaluation of plasma exosome RNA biomarkers for non-invasive diagnosis of hepatocellular carcinoma using RNA-seq.

Journal: BMC cancer

Published: May 04, 2024

Downregulated KLF4, induced by m6A modification, aggravates intestinal barrier dysfunction in inflammatory bowel disease.

Downregulated KLF4, induced by m6A modification, aggravates intestinal barrier dysfunction in inflammatory bowel disease.

Journal: Cellular and molecular life sciences : CMLS

Published: April 16, 2024

BUB1 potentiates gastric cancer proliferation and metastasis by activating TRAF6/NF-κB/FGF18 through m6A modification.

BUB1 potentiates gastric cancer proliferation and metastasis by activating TRAF6/NF-κB/FGF18 through m6A modification.

Journal: Life sciences

Published: January 30, 2024

NR4A1 depletion inhibits colorectal cancer progression by promoting necroptosis via the RIG-I-like receptor pathway.

NR4A1 depletion inhibits colorectal cancer progression by promoting necroptosis via the RIG-I-like receptor pathway.

Journal: Cancer letters

Published: September 28, 2023

HOOK3 suppresses proliferation and metastasis in gastric cancer via the SP1/VEGFA axis.

HOOK3 suppresses proliferation and metastasis in gastric cancer via the SP1/VEGFA axis.

Journal: Cell death discovery

Published: September 25, 2023

ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT/FBLN2 axis.

ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT/FBLN2 axis.

Journal: Journal of cellular and molecular medicine

Published: August 23, 2023

HES1 promotes aerobic glycolysis and cancer progression of colorectal cancer via IGF2BP2-mediated GLUT1 m6A modification.

HES1 promotes aerobic glycolysis and cancer progression of colorectal cancer via IGF2BP2-mediated GLUT1 m6A modification.

Journal: Cell death discovery

Published: August 21, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026